Joseph Driscoll, Chief Financial Officer at Akoya Biosciences, Inc. (AKYA), sold 49,226 shares at $12.46 ($618K) on 2022-12-14, disclosed to the SEC on 2022-12-16.
Open-market sale of $618k AKYA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.46 | 14,574 | $182K | 29.4% |
| 2 | $12.46 | 14,574 | $182K | 29.4% |
| 3 | $12.67 | 10,039 | $127K | 20.6% |
| 4 | $12.67 | 10,039 | $127K | 20.6% |
| Total | $12.55 avg | 49,226 | $618K | 100% |
| Filing → |
| QTRX | SELL | 2018-12-06 | $369K | — | Filing → |
| QTRX | SELL | 2018-11-30 | $356K | — | Filing → |
| QTRX | SELL | 2018-11-16 | $830K | — | Filing → |